Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$276M |
| 2 |
Home Depot
HD
|
+$240M |
| 3 |
TE Connectivity
TEL
|
+$232M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$191M |
| 5 |
SHPG
Shire pic
SHPG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$279M |
| 2 |
Meta Platforms (Facebook)
META
|
+$271M |
| 3 |
NVIDIA
NVDA
|
+$233M |
| 4 |
Cadence Design Systems
CDNS
|
+$222M |
| 5 |
CSX Corp
CSX
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Healthcare | 15.52% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
A.O. Smith
AOS
$8.38B
| $434M | 0.26% |
7,089,679
-486,501
| -6% | -$29.5M |
|
102
NextEra Energy
NEE
$187B
| $433M | 0.26% |
11,096,660
+2,500,704
| +29% | +$96.5M |
|
103
MSCI
MSCI
$40B
| $433M | 0.26% |
3,421,280
-173,198
| -5% | -$21.6M |
|
|
104
Puma Biotechnology
PBYI
$406M
| $431M | 0.26% |
4,355,643
+2,464,742
| +130% | +$276M |
|
105
Ametek
AME
$55.5B
| $428M | 0.26% |
5,911,861
+272,259
| +5% | +$19M |
|
106
PepsiCo
PEP
$186B
| $426M | 0.26% |
3,550,370
-17,216
| -0.5% | -$1.97M |
|
107
Pfizer
PFE
$140B
| $425M | 0.26% |
12,347,050
+645,844
| +6% | +$22M |
|
|
VAR
108
DELISTED
Varian Medical Systems, Inc.
VAR
| $423M | 0.26% |
3,803,408
+264,591
| +7% | +$28.4M |
|
109
Synchrony
SYF
$23.7B
| $418M | 0.25% |
10,830,320
-82,261
| -0.8% | -$2.81M |
|
110
Carter's
CRI
$1.43B
| $417M | 0.25% |
3,547,714
+136,494
| +4% | +$14.1M |
|
111
Waters Corp
WAT
$36.8B
| $415M | 0.25% |
2,148,326
+188,476
| +10% | +$36.4M |
|
112
Procter & Gamble
PG
$343B
| $407M | 0.25% |
4,426,749
+121,257
| +3% | +$10.9M |
|
|
113
NVIDIA
NVDA
$5.01T
| $406M | 0.25% |
83,827,200
-46,853,720
| -36% | -$233M |
|
114
Teledyne Technologies
TDY
$30.4B
| $405M | 0.25% |
2,233,845
+37,110
| +2% | +$6.52M |
|
115
Fidelity National Information Services
FIS
$21.5B
| $404M | 0.25% |
4,292,550
-289,052
| -6% | -$27.2M |
|
116
Belden
BDC
$4B
| $403M | 0.25% |
5,223,419
+150,766
| +3% | +$12.5M |
|
117
HEICO Corp Class A
HEI.A
$35.4B
| $401M | 0.24% |
7,925,088
-564,115
| -7% | -$27.6M |
|
118
Micron Technology
MU
$1.04T
| $401M | 0.24% |
9,741,408
-2,383,666
| -20% | -$103M |
|
|
SCHW
119
Charles Schwab
SCHW
$177B
| $394M | 0.24% |
7,670,948
-792,748
| -9% | -$37.2M |
|
120
General Motors
GM
$74.7B
| $394M | 0.24% |
9,603,226
-1,211,925
| -11% | -$52.6M |
|
121
Zurn Elkay Water Solutions
ZWS
$8.07B
| $391M | 0.24% |
31,221,765
+1,789,263
| +6% | +$21.6M |
|
122
Norwegian Cruise Line
NCLH
$8.89B
| $387M | 0.24% |
7,267,983
-964,569
| -12% | -$53.4M |
|
123
Thermo Fisher Scientific
TMO
$211B
| $385M | 0.23% |
2,027,379
+33,782
| +2% | +$6.47M |
|
124
KLA
KLAC
$275B
| $383M | 0.23% |
36,496,200
-8,672,830
| -19% | -$91.4M |
|
125
Accenture
ACN
$89.9B
| $383M | 0.23% |
2,502,168
+10,565
| +0.4% | +$1.53M |
|
Similar funds
Janus Henderson Group's Q4 2017 Portfolio in Review
As of Q4 2017, Janus Henderson Group held 1,379 positions worth $165B, up 5.4% from $156B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q4 2017 filing shows 95 new, 535 increased, 621 reduced and 76 closed positions. Its largest new stake was Invitation Homes: 5,558,350 shares worth $131M. The largest sale was Lowe's Companies, an estimated $279M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2017 buy was Invitation Homes: 5,558,350 shares worth $131M.
- Janus Henderson Group added most to Puma Biotechnology in Q4 2017, an estimated $276M increase.
- Janus Henderson Group's biggest Q4 2017 reduction was Lowe's Companies, cutting an estimated $279M.
- Janus Henderson Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $124M.
- Janus Henderson Group's ten largest holdings make up 14% of its $165B portfolio in Q4 2017.
- Janus Henderson Group opened 95 new positions and closed 76 in Q4 2017.
- Janus Henderson Group's portfolio value rose 5.4% quarter-over-quarter to $165B.
Based on Janus Henderson Group's 13F filing for Q4 2017, filed 9 Feb 2018.